Back to announcement
20231211_SCPI_Perubahan Profesi Penunjang_31558303.pdf
Other Text extracted SCPISource file signed link, expires in 15 minutes
Extracted text 3
Page 1
Go To English Page
Nomor Surat 055/CS-OPI/12/2023
Nama Perusahaan PT Organon Pharma Indonesia Tbk
Kode Emiten SCPI
Lampiran 1
Perihal Perubahan Kantor Akuntan Publik dan/atau Akuntan Publik
Perubahan KAP
Sesuai hasil Rapat Umum Pemegang Saham yang diselenggarakan tanggal 06 Juni 2023 Berdasarkan Persetujuan
RUPS Perseroan memutuskan menggunakan jasa Kantor Akuntan Publik Tanuderedja, Wibisana, Rintis & Rekan
dengan Akuntan Publik (Signing Partner) yaitu Bapak Steven Tanggara untuk melakukan audit terhadap laporan
keuangan perseroan yang berakhir pada tanggal 31 Desember 2023
Pertimbangan dalam memutuskan perubahan Akuntan Publik adalah sebagai berikut :
1. KAP Tanudiredja, Wibisana, Rintis & Rekan beserta orang di dalam KAP merupakan pihak independen dan bukan
merupakan orang dalam Perseroan dan senantiasa bersikap independen, objektif, dan profesional dalam memberikan
jasanya.
2. Ruang lingkup audit yang dilaksanakan sudah sesuai dengan tanggung jawab dan kriteria penugasan yang diberikan.
3. Imbalan Jasa Audit sudah sesuai dengan kesepakatan kedua belah pihak.
4. KAP Tanudiredja, Wibisana, Rintis & Rekan telah memperoleh izin menjadi Akuntan Publik dan terdaftar di OJK dan
tidak pernah melakukan perbuatan tercela dan/atau dihukum karena terbukti melakukan tindak pidana dibidang
keuangan serta tidak memiliki kredit macet.
5. KAP Tanudiredja, Wibisana, Rintis & Rekan telah melaksanakan audit sesuai dengan Standar Akuntansi Keuangan
yang berlaku di Indonesia dan memberikan opini berdasarkan standar audit yang ditetapkan oleh Institut Akuntan Publik
Indonesia.
6. KAP Tanudiredja, Wibisana, Rintis & Rekan memiliki banyak Akuntan Publik bersertifikat, sehingga dapat mengurangi
risiko atas penggunaan jasa audit oleh KAP yang sama secara berturut-turut.
Demikian untuk diketahui.
Hormat Kami,
PT Organon Pharma Indonesia Tbk
Anjaz Hilman
approver dua
PT Organon Pharma Indonesia Tbk
Sinarmas MSIG Tower, Lantai 37, unit 102 & 106, Jalan Jenderal Sudirman Kaveling
Telepon : 085951102178, Fax : 021-31107009, https://www.organon.com/indonesia/
Nama Pengirim Anjaz Hilman
Jabatan approver dua
Tanggal dan Waktu 11-12-2023 14:04
Lampiran 1. OPI - Surat Penunjukan KAP - FY 2023.pdf
Dokumen ini merupakan dokumen resmi PT Organon Pharma Indonesia Tbk yang tidak memerlukan tanda tangan
karena dihasilkan secara elektronik oleh sistem pelaporan elektronik. PT Organon Pharma Indonesia Tbk
bertanggung jawab penuh atas informasi yang tertera didalam dokumen ini.
Page 2
Go To Indonesian Page Letter / Announcement No. 055/CS-OPI/12/2023 Issuer Name PT Organon Pharma Indonesia Tbk Issuer Code SCPI Attachment 1 Subject Change of Public Accountant Change of Public Accountant According to the results of the General Meeting of Shareholders held on 06 June 2023 Based on: GMS Approval , The Company decided to use the services of a Public Accounting Firm: Tanuderedja, Wibisana, Rintis & Rekan with Public Accountant (Signing Partner), namely: Mr. Steven Tanggara To conduct an audit of the company's financial statements ending on 31 December 2023 The decision to change the Issuer’s Public Accountant was based on the following considerations: 1. KAP Tanudiredja, Wibisana, Rintis & Rekan, and the people within KAP are independent parties and are not people within the Company and always act independently, objectively, and professionally in providing their services. 2. The scope of the audit carried out is in accordance with the responsibilities and assignment criteria given. 3. Fees for audit services are in accordance with the agreement between both parties. 4. KAP Tanudiredja, Wibisana, Rintis & Partners has obtained a license to become a Public Accountant and is registered with the OJK and has never committed any disgraceful act and/or been punished for being proven to have committed a criminal offense in the financial sector and has no bad credit. 5. KAP Tanudiredja, Wibisana, Rintis & Partners has carried out an audit in accordance with the Financial Accounting Standards applicable in Indonesia and provided an opinion based on audit standards set by the Indonesian Institute of Public Accountants. 6. KAP Tanudiredja, Wibisana, Rintis & Rekan has many certified Public Accountants, so it can reduce the risk of using audit services by the same KAP consecutively. Thus to be informed accordingly. Respectfully, PT Organon Pharma Indonesia Tbk Anjaz Hilman approver dua PT Organon Pharma Indonesia Tbk Sinarmas MSIG Tower, Lantai 37, unit 102 & 106, Jalan Jenderal Sudirman Kaveling Phone : 085951102178, Fax : 021-31107009, https://www.organon.com/indonesia/ Sender Name Anjaz Hilman Function approver dua Date and Time 11-12-2023 14:04 Attachment 1. OPI - Surat Penunjukan KAP - FY 2023.pdf
Page 3
This is an official document of PT Organon Pharma Indonesia Tbk that does not require a signature as it was
generated electronically by the electronic reporting system. PT Organon Pharma Indonesia Tbk is fully responsible
for the information contained within this document.
Names mentioned 0 people and organisations named in the text · linked when the evidence is strong
The name pass has not read this document yet.
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.